These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 16009055

  • 21. Transient immunomodulation by intravenous methylprednisolone treatment of multiple sclerosis.
    Crockard AD, Treacy MT, Droogan AG, McNeill TA, Hawkins SA.
    Mult Scler; 1995 Apr; 1(1):20-4. PubMed ID: 9345465
    [Abstract] [Full Text] [Related]

  • 22. Oral low-dose glucocorticosteroids as compared with intravenous methylprednisolone pulses in the treatment of rheumatoid arthritis.
    Dessein PH, Shipton EA, Budd K.
    Rheumatology (Oxford); 1999 Dec; 38(12):1304-5. PubMed ID: 10587571
    [No Abstract] [Full Text] [Related]

  • 23. Preventive effects of intrathecal methylprednisolone administration on spinal cord ischemia in rats: the role of excitatory amino acid metabolizing systems.
    Wu GJ, Chen WF, Sung CS, Jean YH, Shih CM, Shyu CY, Wen ZH.
    Neuroscience; 2007 Jun 29; 147(2):294-303. PubMed ID: 17543466
    [Abstract] [Full Text] [Related]

  • 24. High efficacy of bolus methylprednisolone in severe leptospirosis: a descriptive study in Sri Lanka.
    Kularatne SA, Budagoda BD, de Alwis VK, Wickramasinghe WM, Bandara JM, Pathirage LP, Gamlath GR, Wijethunga TJ, Jayalath WA, Jayasinghe C, Pinto V, Somaratne P, Kumarasiri PV.
    Postgrad Med J; 2011 Jan 29; 87(1023):13-7. PubMed ID: 21106802
    [Abstract] [Full Text] [Related]

  • 25. Anaphylactic reaction to methylprednisolone in multiple sclerosis: a practical approach to alternative corticosteroids.
    Deruaz CA, Spertini F, Souza Lima F, Du Pasquier RA, Schluep M.
    Mult Scler; 2007 May 29; 13(4):559-60. PubMed ID: 17463078
    [No Abstract] [Full Text] [Related]

  • 26. Heterogeneity of aquaporin-4 autoimmunity and spinal cord lesions in multiple sclerosis in Japanese.
    Matsuoka T, Matsushita T, Kawano Y, Osoegawa M, Ochi H, Ishizu T, Minohara M, Kikuchi H, Mihara F, Ohyagi Y, Kira J.
    Brain; 2007 May 29; 130(Pt 5):1206-23. PubMed ID: 17439988
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Calcification and ossification of the spinal arachnoid after intrathecal administration of Depo-Medrol.
    Carta F, Canu C, Datti R, Guiducci G, Pisani R, Silvestro C.
    Zentralbl Neurochir; 1987 May 29; 48(3):256-61. PubMed ID: 3124393
    [Abstract] [Full Text] [Related]

  • 30. Postpartum activation of multiple sclerosis: MRI imaging and immunological characterization of a case.
    Saraste MH, Kurki T, Airas LM.
    Eur J Neurol; 2006 Jan 29; 13(1):98-9. PubMed ID: 16420404
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Gadolinium-enhanced magnetic resonance imaging predicts response to methylprednisolone in multiple sclerosis.
    Sellebjerg F, Jensen CV, Larsson HB, Frederiksen JL.
    Mult Scler; 2003 Feb 29; 9(1):102-7. PubMed ID: 12617276
    [Abstract] [Full Text] [Related]

  • 33. [Our contemporary experiences with the intrathecal treatment of multiple sclerosis using depot corticoids. I. Clinical results].
    Hanák L, Zouhar A.
    Cesk Neurol Neurochir; 1974 Sep 29; 37(5):287-92. PubMed ID: 4479028
    [No Abstract] [Full Text] [Related]

  • 34. Experimental intrathecal administration of methylprednisolone acetate in multiple sclerosis.
    Goldstein NP, McGuckin WF, McKenzie BF, Mattox VR.
    Trans Am Neurol Assoc; 1970 Sep 29; 95():243-4. PubMed ID: 5537958
    [No Abstract] [Full Text] [Related]

  • 35. Clinical and histological effects of the intrathecal administration of methylprednisolone in dogs.
    Lima RM, Navarro LH, Carness JM, Barros GA, Marques ME, Solanki D, Ganem EM.
    Pain Physician; 2010 Sep 29; 13(5):493-501. PubMed ID: 20859319
    [Abstract] [Full Text] [Related]

  • 36. Glucocorticoid therapy and memory function: lessons learned from basic research.
    Roozendaal B, de Quervain DJ.
    Neurology; 2005 Jan 25; 64(2):184-5. PubMed ID: 15668410
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The use of pulse corticosteroid therapy for juvenile dermatomyositis.
    Paller AS.
    Pediatr Dermatol; 1996 Jan 25; 13(4):347-8. PubMed ID: 8844758
    [No Abstract] [Full Text] [Related]

  • 39. Early immunosuppressive effect of parenteral methylprednisolone in the treatment of multiple sclerosis.
    Durelli L, Baggio GF, Bergamasco B, Barile C, Cocito D, Delsedime M, Perla F, Riccio A, Bergamini L.
    Acta Neurol (Napoli); 1985 Jan 25; 7(3-4):338-44. PubMed ID: 3904340
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.